Fig. 1From: Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapyChanges in the ability to talk to medication prescriber since the beginning of COVID-19 pandemic amongst respondents who were unable to talk, able to talk, and did not want to talk to their medication prescriber (n = 441)Back to article page